Fredrik Lehmann
Direktor/Vorstandsmitglied bei GUARD THERAPEUTICS INTERNATIONAL AB
Ursprung des Netzwerks ersten Grades von Fredrik Lehmann
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
University of Gothenburg
21
| College/University | Other Consumer Services | 21 |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm.
15
| Private Company | Investment Managers | 15 |
| Public Company | Pharmaceuticals: Major | 12 | |
Stockholm School of Economics
10
| College/University | Other Consumer Services | 10 |
| Public Company | Pharmaceuticals: Major | 10 | |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden.
8
| Holding Company | Medical Specialties | 8 |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fredrik Lehmann
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Uppsala | College/University | Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Stockholm | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| University of Lund | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Oncopeptides Incentive AB | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | ||
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal General Counsel General Counsel | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Investor Relations Contact | |
| Pfizer AB | Corporate Officer/Principal Corporate Officer/Principal Public Communications Contact | ||
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| DIAMYD MEDICAL AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
EQT Partners AB
 EQT Partners AB Investment ManagersFinance EQT Partners AB (EQT Partners) is a private equity subsidiary of EQT AB founded in 1994 by Yngve Conni Jonsson. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Chief Operating Officer Private Equity Analyst | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
eEquity AB
 eEquity AB Investment ManagersFinance eEquity AB (eEquity) is a private equity firm founded by Jens Patrik Hedelin and Magnus Stefan Wiberg in 2010. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor Private Equity Analyst | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| SCANDI STANDARD AB (PUBL) | Food: Meat/Fish/Dairy | Chairman Director/Board Member | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Exeri AB
 Exeri AB Information Technology ServicesTechnology Services Exeri AB engages in the provision of telecom network management and information technology services. The company was founded by Karl Johan Magnus Karlsson in 2009 and is headquartered in Lulea, Sweden. | Information Technology Services | Director/Board Member Director/Board Member | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Sales & Marketing | |
Lexly AB
 Lexly AB Miscellaneous Commercial ServicesCommercial Services Lexly AB offers phone and online legal services for individuals and businesses. It markets a digital attorney in the form of legally binding documents which can be customized, based on the specific needs of each user, via a system based on dynamic software and all legal documents are produced with the help of legal experts. The company was founded by Lars Magnus Stein and Anders Gunnar Birger Perméus in 2004 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| DEVYSER DIAGNOSTICS AB | Medical Specialties | Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Tech/Sci/R&D Officer General Counsel | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Investor Relations Contact | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Chief Operating Officer Investor Relations Contact | |
| COREM PROPERTY GROUP AB | Real Estate Development | Chairman Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Masters Business Admin | |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
GU Ventures AB
 GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Investment Managers | Director/Board Member Director of Finance/CFO | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Chairman Chief Executive Officer | |
| GETINGE AB | Medical Specialties | Director/Board Member Director/Board Member | |
| Miterovia AB | Chairman Chief Executive Officer | ||
Airsonett AB
 Airsonett AB Medical DistributorsDistribution Services Airsonett AB is a holding company that is engaged in the research and development of a non-pharmaceutical treatment for asthma. Its product Airsonett is based on temperature controlled Laminar Airflow technology that creates a radically reduced allergen exposure in the breathing zone for treatment of asthma, allergic rhinitis, and atopic eczema. The company was founded by Jan Tommy Lennart Hedberg, Jan Kristensson, and Dan Kristensson in 2000 and is headquartered in Ängelholm, Sweden. | Medical Distributors | Corporate Officer/Principal Director/Board Member | |
| University of Linnaeus | College/University | Undergraduate Degree Undergraduate Degree |
Statistik
International
| Schweden | 44 |
| Vereinigte Staaten | 7 |
| Norwegen | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 6 |
| Health Services | 2 |
Operativ
| Director/Board Member | 408 |
| Corporate Officer/Principal | 149 |
| Chairman | 82 |
| Independent Dir/Board Member | 74 |
| Chief Executive Officer | 61 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Fredrik Lehmann
- Unternehmensverbindungen
